Valero or Divi's Laboratories — which is the better buy?

The honest answer comes from running the same workflow on both: quality score, valuation ceiling versus today's price, and which thesis breaks worry you more. The snapshot table below gives the current dated state of each.

How are VLO and DIVISLAB.NS different?

Valero trades on US (Energy); Divi's Laboratories trades on India (Pharma). Market, currency, liquidity, and disclosure regimes differ — the workflow stays identical, so the comparison is fair.

Comparison · Updated 2026-08-29

Valero vs Divi's Laboratories

By the Balance Labs Research Desk · Reviewed by the editorial review board · 2026-08-29

Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.

Key facts — quick answer

VLO = Valero (US) · DIVISLAB.NS = Divi's Laboratories (India).
Snapshot 2026-08-29: VLO $348.03 · signal LONG · ret +159.6% ‖ DIVISLAB.NS ₹9,121 · signal LONG · ret +25.3%.
The one with the wider gap between price and its valuation ceiling — at equal quality — usually wins the slot.

Snapshot comparison (2026-08-29)

	VLO	DIVISLAB.NS
Company	Valero	Divi's Laboratories
Market	🇺🇸 US	🇮🇳 India
Sector	Energy	Pharma
Price	$348.03	₹9,121
Signal	LONG · +159.6%	LONG · +40.9%
Total return	+159.6%	+25.3%

Decide it with the calculator

Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.

Open both briefs

VLO decision brief DIVISLAB.NS decision brief

★

Get more Balance Labs in your Google results

Add balancelabs.app as a Preferred Source on Google.

← All guides · Home · Data snapshot 2026-08-29 · Not investment advice.